View in EDS

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Saved in:
Bibliographic Details
Title: Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Authors: Grover P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Li I; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Kuijpers AMJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kreidieh F; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Williamson A; The Christie NHS Foundation Trust, Manchester, UK., Amaral T; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Dimitriou F; Department of Dermatology, Faculty of Medicine, University Hospital of Zurich, Zurich, Switzerland., Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Olino K; Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, New Haven, USA., Vitale MG; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy., Saiag P; University Department of Dermatology, Université de Versailles-Saint Quentin en Yvelines, APHP, Boulogne, France., Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany., Allayous C; AP-HP Dermato-oncology, Cancer Institute APHP Nord Paris Cité, Saint Louis Hospital, Paris, France., Olofsson Bagge R; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg., Mattsson J; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Asher N; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel HaShomer, Israel., Carter TJ; Mount Vernon Cancer Centre, Northwood, UK., Meniawy TM; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia., Lawless AR; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA., Czapla JA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA., Warburton L; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, Australia., Gaudy-Marqueste C; Aix-Marseille Univ, APHM, Hôpital Timone, Service de dermatologie et de cancérologie cutanée, Marseille, France., Grob JJ; Aix-Marseille Univ, APHM, Hôpital Timone, Service de dermatologie et de cancérologie cutanée, Marseille, France., Collins RG; Vanderbilt University School of Medicine, Nashville, USA., Zhang E; Department of Surgery, Westmead Hospital, Sydney, Australia., Kessels JI; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Mehmi I; Cedars-Sinai The Angeles Clinic and Research Institute, Los Angeles, USA., Hamid O; Cedars-Sinai The Angeles Clinic and Research Institute, Los Angeles, USA., Julve M; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK., Furness AJS; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK., Margolin KA; Department of Medical Oncology, Providence St. John's Cancer Institute, Santa Monica., Lev-Ari S; Georgetown Lombardi Comprehensive Cancer Center, Washington, USA., Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Haque W; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, USA., Khattak MA; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia., Wicky A; Oncology, Lausanne University Hospital, Lausanne, Switzerland., Roberts-Thomson R; Medical Oncology Department, The Queen Elizabeth Hospital, Adelaide, Australia., Arance A; Hospital Clínic Barcelona and IDIBAPS, Barcelona, Spain., Warrier G; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA., Schollenberger MD; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA., Parente P; Eastern Health Clinical School, Box Hill Hospital, Monash University, Melbourne, Australia., Chatziioannou E; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Lipson EJ; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA., Michielin O; Department of Oncology, Geneva University Hospital, Geneva, Switzerland., Weber JS; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, USA., Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Larkin J; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, USA., Essner R; Department of Surgery, Saint John's Cancer Institute at Providence St. John's Health Center, Santa Monica, USA., Johnson DB; Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, USA., Sullivan RJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA., Nathan P; Mount Vernon Cancer Centre, Northwood, UK., Schachter J; Sheba Medical Center-Tel HaShomer, Ramat Gan, Israel., Lebbe C; Université Paris Cite, APHP Dermato-oncology, Cancer Institute APHP Nord Paris Cité, INSERM U976, Saint Louis Hospital, Paris, France., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy., Kluger H; Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, New Haven, USA., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Dummer R; Department of Dermatology, Faculty of Medicine, University Hospital of Zurich, Zurich, Switzerland., Garbe C; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany., Lorigan PC; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK., Burton E; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Tawbi HA; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Haanen J; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Carlino MS; Westmead and Blacktown Hospitals, University of Sydney, Melanoma Institute Australia, Sydney, Australia., Menzies AM; Melanoma Institute Australia, University of Sydney, Mater and Royal North Shore Hospitals, Australia., Long GV; Melanoma Institute Australia, University of Sydney, Mater and Royal North Shore Hospitals, Australia. Electronic address: Georgina.long@sydney.edu.au.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2025 Jul; Vol. 36 (7), pp. 807-818. Date of Electronic Publication: 2025 Apr 08.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40204154
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Grover+P%22">Grover P</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia.<br /><searchLink fieldCode="AU" term="%22Lo+SN%22">Lo SN</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Li+I%22">Li I</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Kuijpers+AMJ%22">Kuijpers AMJ</searchLink>; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kreidieh+F%22">Kreidieh F</searchLink>; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Williamson+A%22">Williamson A</searchLink>; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Amaral+T%22">Amaral T</searchLink>; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Dimitriou+F%22">Dimitriou F</searchLink>; Department of Dermatology, Faculty of Medicine, University Hospital of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Placzke+J%22">Placzke J</searchLink>; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Olino+K%22">Olino K</searchLink>; Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, New Haven, USA.<br /><searchLink fieldCode="AU" term="%22Vitale+MG%22">Vitale MG</searchLink>; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Saiag+P%22">Saiag P</searchLink>; University Department of Dermatology, Université de Versailles-Saint Quentin en Yvelines, APHP, Boulogne, France.<br /><searchLink fieldCode="AU" term="%22Gutzmer+R%22">Gutzmer R</searchLink>; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany.<br /><searchLink fieldCode="AU" term="%22Allayous+C%22">Allayous C</searchLink>; AP-HP Dermato-oncology, Cancer Institute APHP Nord Paris Cité, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Olofsson+Bagge+R%22">Olofsson Bagge R</searchLink>; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg.<br /><searchLink fieldCode="AU" term="%22Mattsson+J%22">Mattsson J</searchLink>; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Asher+N%22">Asher N</searchLink>; The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel HaShomer, Israel.<br /><searchLink fieldCode="AU" term="%22Carter+TJ%22">Carter TJ</searchLink>; Mount Vernon Cancer Centre, Northwood, UK.<br /><searchLink fieldCode="AU" term="%22Meniawy+TM%22">Meniawy TM</searchLink>; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia.<br /><searchLink fieldCode="AU" term="%22Lawless+AR%22">Lawless AR</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Czapla+JA%22">Czapla JA</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Warburton+L%22">Warburton L</searchLink>; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Perth, Australia.<br /><searchLink fieldCode="AU" term="%22Gaudy-Marqueste+C%22">Gaudy-Marqueste C</searchLink>; Aix-Marseille Univ, APHM, Hôpital Timone, Service de dermatologie et de cancérologie cutanée, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Grob+JJ%22">Grob JJ</searchLink>; Aix-Marseille Univ, APHM, Hôpital Timone, Service de dermatologie et de cancérologie cutanée, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Collins+RG%22">Collins RG</searchLink>; Vanderbilt University School of Medicine, Nashville, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+E%22">Zhang E</searchLink>; Department of Surgery, Westmead Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Kessels+JI%22">Kessels JI</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Neyns+B%22">Neyns B</searchLink>; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Mehmi+I%22">Mehmi I</searchLink>; Cedars-Sinai The Angeles Clinic and Research Institute, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Hamid+O%22">Hamid O</searchLink>; Cedars-Sinai The Angeles Clinic and Research Institute, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Julve+M%22">Julve M</searchLink>; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Furness+AJS%22">Furness AJS</searchLink>; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Margolin+KA%22">Margolin KA</searchLink>; Department of Medical Oncology, Providence St. John's Cancer Institute, Santa Monica.<br /><searchLink fieldCode="AU" term="%22Lev-Ari+S%22">Lev-Ari S</searchLink>; Georgetown Lombardi Comprehensive Cancer Center, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Ressler+JM%22">Ressler JM</searchLink>; Department of Dermatology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Haque+W%22">Haque W</searchLink>; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Khattak+MA%22">Khattak MA</searchLink>; Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia.<br /><searchLink fieldCode="AU" term="%22Wicky+A%22">Wicky A</searchLink>; Oncology, Lausanne University Hospital, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Roberts-Thomson+R%22">Roberts-Thomson R</searchLink>; Medical Oncology Department, The Queen Elizabeth Hospital, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Arance+A%22">Arance A</searchLink>; Hospital Clínic Barcelona and IDIBAPS, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Warrier+G%22">Warrier G</searchLink>; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA.<br /><searchLink fieldCode="AU" term="%22Schollenberger+MD%22">Schollenberger MD</searchLink>; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA.<br /><searchLink fieldCode="AU" term="%22Parente+P%22">Parente P</searchLink>; Eastern Health Clinical School, Box Hill Hospital, Monash University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Chatziioannou+E%22">Chatziioannou E</searchLink>; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lipson+EJ%22">Lipson EJ</searchLink>; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins, Baltimore, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, Baltimore, USA.<br /><searchLink fieldCode="AU" term="%22Michielin+O%22">Michielin O</searchLink>; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Weber+JS%22">Weber JS</searchLink>; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Hoeller+C%22">Hoeller C</searchLink>; Department of Dermatology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Larkin+J%22">Larkin J</searchLink>; Renal, Skin and Cell Therapy Unit, The Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Atkins+MB%22">Atkins MB</searchLink>; Georgetown Lombardi Comprehensive Cancer Center, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Essner+R%22">Essner R</searchLink>; Department of Surgery, Saint John's Cancer Institute at Providence St. John's Health Center, Santa Monica, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+DB%22">Johnson DB</searchLink>; Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, USA.<br /><searchLink fieldCode="AU" term="%22Sullivan+RJ%22">Sullivan RJ</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Nathan+P%22">Nathan P</searchLink>; Mount Vernon Cancer Centre, Northwood, UK.<br /><searchLink fieldCode="AU" term="%22Schachter+J%22">Schachter J</searchLink>; Sheba Medical Center-Tel HaShomer, Ramat Gan, Israel.<br /><searchLink fieldCode="AU" term="%22Lebbe+C%22">Lebbe C</searchLink>; Université Paris Cite, APHP Dermato-oncology, Cancer Institute APHP Nord Paris Cité, INSERM U976, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ascierto+PA%22">Ascierto PA</searchLink>; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Kluger+H%22">Kluger H</searchLink>; Yale University School of Medicine, Smilow Cancer Center, New Haven Hospital, New Haven, USA.<br /><searchLink fieldCode="AU" term="%22Rutkowski+P%22">Rutkowski P</searchLink>; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Dummer+R%22">Dummer R</searchLink>; Department of Dermatology, Faculty of Medicine, University Hospital of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Garbe+C%22">Garbe C</searchLink>; Center for Dermato-oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lorigan+PC%22">Lorigan PC</searchLink>; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Burton+E%22">Burton E</searchLink>; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Tawbi+HA%22">Tawbi HA</searchLink>; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Haanen+J%22">Haanen J</searchLink>; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Carlino+MS%22">Carlino MS</searchLink>; Westmead and Blacktown Hospitals, University of Sydney, Melanoma Institute Australia, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Menzies+AM%22">Menzies AM</searchLink>; Melanoma Institute Australia, University of Sydney, Mater and Royal North Shore Hospitals, Australia.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, University of Sydney, Mater and Royal North Shore Hospitals, Australia. Electronic address: Georgina.long@sydney.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2025 Jul; Vol. 36 (7), pp. 807-818. <i>Date of Electronic Publication: </i>2025 Apr 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40204154
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.03.021
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 807
    Titles:
      – TitleFull: Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Grover P
      – PersonEntity:
          Name:
            NameFull: Lo SN
      – PersonEntity:
          Name:
            NameFull: Li I
      – PersonEntity:
          Name:
            NameFull: Kuijpers AMJ
      – PersonEntity:
          Name:
            NameFull: Kreidieh F
      – PersonEntity:
          Name:
            NameFull: Williamson A
      – PersonEntity:
          Name:
            NameFull: Amaral T
      – PersonEntity:
          Name:
            NameFull: Dimitriou F
      – PersonEntity:
          Name:
            NameFull: Placzke J
      – PersonEntity:
          Name:
            NameFull: Olino K
      – PersonEntity:
          Name:
            NameFull: Vitale MG
      – PersonEntity:
          Name:
            NameFull: Saiag P
      – PersonEntity:
          Name:
            NameFull: Gutzmer R
      – PersonEntity:
          Name:
            NameFull: Allayous C
      – PersonEntity:
          Name:
            NameFull: Olofsson Bagge R
      – PersonEntity:
          Name:
            NameFull: Mattsson J
      – PersonEntity:
          Name:
            NameFull: Asher N
      – PersonEntity:
          Name:
            NameFull: Carter TJ
      – PersonEntity:
          Name:
            NameFull: Meniawy TM
      – PersonEntity:
          Name:
            NameFull: Lawless AR
      – PersonEntity:
          Name:
            NameFull: Czapla JA
      – PersonEntity:
          Name:
            NameFull: Warburton L
      – PersonEntity:
          Name:
            NameFull: Gaudy-Marqueste C
      – PersonEntity:
          Name:
            NameFull: Grob JJ
      – PersonEntity:
          Name:
            NameFull: Collins RG
      – PersonEntity:
          Name:
            NameFull: Zhang E
      – PersonEntity:
          Name:
            NameFull: Kessels JI
      – PersonEntity:
          Name:
            NameFull: Neyns B
      – PersonEntity:
          Name:
            NameFull: Mehmi I
      – PersonEntity:
          Name:
            NameFull: Hamid O
      – PersonEntity:
          Name:
            NameFull: Julve M
      – PersonEntity:
          Name:
            NameFull: Furness AJS
      – PersonEntity:
          Name:
            NameFull: Margolin KA
      – PersonEntity:
          Name:
            NameFull: Lev-Ari S
      – PersonEntity:
          Name:
            NameFull: Ressler JM
      – PersonEntity:
          Name:
            NameFull: Haque W
      – PersonEntity:
          Name:
            NameFull: Khattak MA
      – PersonEntity:
          Name:
            NameFull: Wicky A
      – PersonEntity:
          Name:
            NameFull: Roberts-Thomson R
      – PersonEntity:
          Name:
            NameFull: Arance A
      – PersonEntity:
          Name:
            NameFull: Warrier G
      – PersonEntity:
          Name:
            NameFull: Schollenberger MD
      – PersonEntity:
          Name:
            NameFull: Parente P
      – PersonEntity:
          Name:
            NameFull: Chatziioannou E
      – PersonEntity:
          Name:
            NameFull: Lipson EJ
      – PersonEntity:
          Name:
            NameFull: Michielin O
      – PersonEntity:
          Name:
            NameFull: Weber JS
      – PersonEntity:
          Name:
            NameFull: Hoeller C
      – PersonEntity:
          Name:
            NameFull: Larkin J
      – PersonEntity:
          Name:
            NameFull: Atkins MB
      – PersonEntity:
          Name:
            NameFull: Essner R
      – PersonEntity:
          Name:
            NameFull: Johnson DB
      – PersonEntity:
          Name:
            NameFull: Sullivan RJ
      – PersonEntity:
          Name:
            NameFull: Nathan P
      – PersonEntity:
          Name:
            NameFull: Schachter J
      – PersonEntity:
          Name:
            NameFull: Lebbe C
      – PersonEntity:
          Name:
            NameFull: Ascierto PA
      – PersonEntity:
          Name:
            NameFull: Kluger H
      – PersonEntity:
          Name:
            NameFull: Rutkowski P
      – PersonEntity:
          Name:
            NameFull: Dummer R
      – PersonEntity:
          Name:
            NameFull: Garbe C
      – PersonEntity:
          Name:
            NameFull: Lorigan PC
      – PersonEntity:
          Name:
            NameFull: Burton E
      – PersonEntity:
          Name:
            NameFull: Tawbi HA
      – PersonEntity:
          Name:
            NameFull: Haanen J
      – PersonEntity:
          Name:
            NameFull: Carlino MS
      – PersonEntity:
          Name:
            NameFull: Menzies AM
      – PersonEntity:
          Name:
            NameFull: Long GV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1